Lenalidomide ‐associated progressive multifocal leukoencephalopathy

ConclusionsAlthough rare, lenalidomide ‐induced PML should be considered in myeloma patients treated with lenalidomide.

Source: Clinical and Experimental Neuroimmunology - February 18, 2021 Category: Neurology Authors: Kazutaka Nishimura, Yuta Iwai, Mariko Yabuki, Hiroe Fuse, Kazuo Nakamichi, Kenta Takahashi, Tadaki Suzuki, Masayuki Saijo, Takeshi Fukushima, Satoshi Kuwabara Tags: CASE REPORT Source Type: research